Bevacizumab 58394-0095-05
- Manufacturer
- Wyeth Biopharma Division Of Wyeth Pharmaceuticals Llc
- Dosage Form
- Liquid
- Product Type
- Drug For Further Processing
- Marketing Start
- September 19, 2019
- Listing Expires
- December 31, 2026
Active Ingredients
| Ingredient | Strength |
|---|---|
| Bevacizumab | 95.5 mg/95.5mL |
Selected Package
58394-0095-05Selected95.5 mL in 1 CONTAINER (58394-095-05)